Printer Friendly

Protein vaccine slows leukemia. (Cancer).

By injecting leukemia patients with part of a protein found in greater abundance on cancerous cells than on healthy ones, researchers have been able to induce some patients' immune systems to fight this blood cancer.

Jeffrey J. Molldrem of the University of Texas M.D. Anderson Cancer Center in Houston and his colleagues fashioned the cancer vaccine from a piece of proteinase 3, a compound overproduced by malignant blood cells in leukemia patients. Earlier research suggested that the piece, called PRI, stimulates production of immune system T cells that specifically target proteinase 3.

Molldrem's group identified 15 patients with leukemia that had resisted other treatment. Each patient received three PRI injections, each separated by 3 weeks. In five people, the leukemia went into remission and their T cells showed a strong attraction to the leukemia cells. Three other patients in the group showed partial responses.

Molldrem and his colleagues are now testing the vaccine in 60 more leukemia patients.--N.S.
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Jan 4, 2003
Previous Article:Hawaii's hated frogs: tiny invaders raise a big ruckus.
Next Article:Getting the iron out. (Anemia).

Related Articles
Vaccine for cats' number one killer.
The AIDS virus: equine similarities?
Renegade tumors.
One-two drug punch trips up leukemia.
Immune cells target cancerous tissue. (Vaccine Power).
Cancer vaccine gets first test in patients. (Immunology).
Tiny bubbles: vesicles that cells spit out are implicated in cancer and AIDS.
Mother's pre-pregnancy diet may influence child cancer risk.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters